NFKB1 and asthma: It was also reported that AUR could treat Th2 cells diseases such as asthma by inhibiting cell proliferation, decreasing the levels of cytokines (IL-4, IL-10, and IFN-γ) and NF-κB, and reducing nitric oxide (NO) production in phytohemagglutinin (PHA) stimulation [42].